Published in J Cereb Blood Flow Metab on September 01, 1991
Measuring endogenous 5-HT release by emission tomography: promises and pitfalls. J Cereb Blood Flow Metab (2010) 1.16
Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects. Proc Natl Acad Sci U S A (1993) 0.88
Kinetic modelling of [11C]flumazenil using data-driven methods. Eur J Nucl Med Mol Imaging (2008) 0.86
In vivo demonstration of altered benzodiazepine receptor density in patients with generalised epilepsy. J Neurol Neurosurg Psychiatry (1994) 0.81
Association of vascular parkinsonism with impaired neuronal integrity in the striatum. J Neural Transm (Vienna) (2007) 0.76
I-123 iomazenil single photon emission computed tomography for detecting loss of neuronal integrity in patients with traumatic brain injury. EJNMMI Res (2017) 0.75
Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol (1997) 10.06
Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain (2008) 6.29
Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol (1979) 5.83
A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med (1995) 4.44
Relationships between biomarkers in aging and dementia. Neurology (2009) 4.16
Age differences in the frontal lateralization of verbal and spatial working memory revealed by PET. J Cogn Neurosci (2000) 3.66
Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science (2001) 3.48
Spatial working memory in humans as revealed by PET. Nature (1993) 3.42
Dissociating verbal and spatial working memory using PET. Cereb Cortex (1996) 3.18
Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol (1980) 3.12
Demonstration of accuracy and clinical versatility of mutual information for automatic multimodality image fusion using affine and thin-plate spline warped geometric deformations. Med Image Anal (1997) 3.10
Verbal Working Memory Load Affects Regional Brain Activation as Measured by PET. J Cogn Neurosci (1997) 3.00
Inhibition in verbal working memory revealed by brain activation. Proc Natl Acad Sci U S A (1998) 3.00
The role of parietal cortex in verbal working memory. J Neurosci (1998) 2.89
Anatomic standardization: linear scaling and nonlinear warping of functional brain images. J Nucl Med (1994) 2.76
Brain activation in PTSD in response to trauma-related stimuli. Biol Psychiatry (1999) 2.38
Components of verbal working memory: evidence from neuroimaging. Proc Natl Acad Sci U S A (1998) 2.15
Posterior cingulate cortex in Alzheimer's disease. Lancet (1994) 2.11
Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol (1990) 2.07
History of falls in Parkinson disease is associated with reduced cholinergic activity. Neurology (2009) 2.01
Automated detection of the intercommissural line for stereotactic localization of functional brain images. J Nucl Med (1993) 1.93
Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2005) 1.89
Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis. J Comput Assist Tomogr (1995) 1.88
Spatial versus Object Working Memory: PET Investigations. J Cogn Neurosci (1995) 1.88
In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease. Neurology (1999) 1.86
Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes. Neurology (2010) 1.79
Epileptic patterns of local cerebral metabolism and perfusion in humans determined by emission computed tomography of 18FDG and 13NH3. Ann Neurol (1980) 1.78
Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan. Ann Neurol (1982) 1.77
Age differences in behavior and PET activation reveal differences in interference resolution in verbal working memory. J Cogn Neurosci (2000) 1.76
Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur J Neurol (2009) 1.76
Metabolic mapping of the brain's response to visual stimulation: studies in humans. Science (1981) 1.75
Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortex. Ann Neurol (2000) 1.73
Comparative localization of epileptic foci in partial epilepsy by PCT and EEG. Ann Neurol (1982) 1.73
Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol (2001) 1.67
Mutual information for automated unwarping of rat brain autoradiographs. Neuroimage (1997) 1.60
Three-dimensional stereotactic surface projection analysis of macaque brain PET: development and initial applications. J Nucl Med (2000) 1.54
Correlation methods for the centering, rotation, and alignment of functional brain images. J Nucl Med (1990) 1.52
Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease. N Engl J Med (1987) 1.51
Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazine. J Cereb Blood Flow Metab (1999) 1.49
A comparison of cerebral blood flow and glucose metabolism in olivopontocerebellar atrophy using PET. Neurology (1995) 1.47
The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. Arch Neurol (1983) 1.47
Pathophysiology, treatment and outcome following severe head injury in children. Childs Brain (1979) 1.46
In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease. Ann Neurol (1996) 1.45
Pathological findings underlying focal temporal lobe hypometabolism in partial epilepsy. Ann Neurol (1982) 1.43
Comparison of human cerebral activation pattern during cutaneous warmth, heat pain, and deep cold pain. J Neurophysiol (1996) 1.42
Neuropsychological changes in olivopontocerebellar atrophy. Arch Neurol (1990) 1.42
Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: I. Are inflammatory cells important? J Nucl Med (1995) 1.42
Quantitation in positron emission computed tomography: 2. Effects of inaccurate attenuation correction. J Comput Assist Tomogr (1979) 1.41
Technetium-99m-N1-(2-mercapto-2-methylpropyl)-N2-(2-propargylthio-2- methylpropyl)-1,2-benzenediamine (T691): preclinical studies of a potential new tracer of regional cerebral perfusion. J Nucl Med (1992) 1.40
Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cereb Blood Flow Metab (1991) 1.40
Isolation of specific interference processing in the Stroop task: PET activation studies. Neuroimage (1997) 1.40
N-13 ammonia as an indicator of myocardial blood flow. Circulation (1981) 1.35
Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging. Ann Neurol (1996) 1.35
Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology (2000) 1.33
Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology (1996) 1.32
Interictal cerebral glucose metabolism in partial epilepsy and its relation to EEG changes. Ann Neurol (1982) 1.32
The neural basis of task-switching in working memory: effects of performance and aging. Proc Natl Acad Sci U S A (2001) 1.30
Limbic activation and psychophysiologic responses to aversive visual stimuli. Interaction with cognitive task. Neuropsychopharmacology (2000) 1.28
Quantitation in positron emission computed tomography: 5. Physical--anatomical effects. J Comput Assist Tomogr (1981) 1.27
Neuropsychological deficits are correlated with frontal hypometabolism in positron emission tomography studies of older alcoholic patients. Alcohol Clin Exp Res (1993) 1.27
"Anatometabolic" tumor imaging: fusion of FDG PET with CT or MRI to localize foci of increased activity. J Nucl Med (1993) 1.26
Reorganizing data from transverse section scans of the brain using digital processing. Radiology (1968) 1.26
Stereotactic PET atlas of the human brain: aid for visual interpretation of functional brain images. J Nucl Med (1994) 1.25
Synthesis of 1-[11C]methylpiperidin-4-yl propionate ([11C]PMP) for in vivo measurements of acetylcholinesterase activity. Nucl Med Biol (1998) 1.24
Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease. Exp Neurol (2003) 1.23
Computed tomography of intracerebral hematomas. I. Transmission CT observations on hematoma resolution. AJR Am J Roentgenol (1977) 1.23
Effects of human aging on patterns of local cerebral glucose utilization determined by the [18F]fluorodeoxyglucose method. J Cereb Blood Flow Metab (1982) 1.21
Patterns of human local cerebral glucose metabolism during epileptic seizures. Science (1982) 1.21
Dual-[11C]tracer single-acquisition positron emission tomography studies. J Cereb Blood Flow Metab (2001) 1.20
Positron emission tomographic analysis of cerebral structures activated specifically by repetitive noxious heat stimuli. J Neurophysiol (1994) 1.20
PET evidence for an amodal verbal working memory system. Neuroimage (1996) 1.19
The effect of emotional content on visual recognition memory: a PET activation study. Neuroimage (1998) 1.19
Increased ventral striatal monoaminergic innervation in Tourette syndrome. Neurology (2003) 1.18
Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET. J Nucl Med (1996) 1.18
ECAT: a new computerized tomographic imaging system for positron-emitting radiopharmaceuticals. J Nucl Med (1978) 1.17
Quantifying local cerebral blood flow by N-isopropyl-p-[123I]iodoamphetamine (IMP) tomography. J Nucl Med (1982) 1.17
Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease. Am J Cardiol (1991) 1.17